Cardiovascular health, heart failure, atherosclerosis, and cardiac research
256 articles
Meta-analysis shows ongericimab dramatically reduces LDL cholesterol and other heart disease risk factors with minimal side effects.
Meta-analysis shows recaticimab dramatically reduces LDL cholesterol and other cardiovascular risk markers with manageable side effects.
Breakthrough siRNA therapy dramatically reduces lipoprotein(a), a stubborn cardiovascular risk factor resistant to statins and lifestyle changes.
New meta-analysis shows PCSK9 inhibitors significantly reduce cardiovascular events and major amputations in PAD patients beyond standard statin therapy.
New research shows most children with inherited high cholesterol go undiagnosed, missing critical early intervention opportunities.
Inclisiran, a breakthrough RNA therapy, dramatically lowered dangerous cholesterol levels in real-world patients with minimal side effects.
Advanced cholesterol-lowering therapies show promise for dramatically reducing cardiovascular disease risk through innovative approaches.
Major analysis of 49,847 patients shows PCSK9 inhibitors significantly reduce heart attacks and strokes beyond standard statin therapy.
New research reveals how regular exercise protects against aortic dissection, a life-threatening cardiovascular emergency.
New mouse study challenges assumptions about triglycerides and aortic health, finding no increased risk of thoracic aneurysms.
Scientists discover how a molecular switch in blood vessel cells accelerates aging and plaque formation, revealing new therapeutic targets.
Major review reveals sleep quality affects cardiovascular health beyond just duration. Multiple sleep factors impact heart disease risk.
